• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: C.R. BARD, INC. (BASD) -3006260740 UNKNOWN PORT; PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

C.R. BARD, INC. (BASD) -3006260740 UNKNOWN PORT; PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR Back to Search Results
Catalog Number UNKNOWN PORT
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Bacterial Infection (1735); Stroke/CVA (1770)
Event Date 07/31/2018
Event Type  Injury  
Manufacturer Narrative
H10: as the lot number for the device was not provided, a review of the device history records could not be performed.The sample was not returned to the manufacturer for inspection/evaluation.Therefore, the investigation of the reported event is inconclusive.Based upon the available information, the definitive root cause for this event is unknown.The instructions for use (ifu) is adequate for the reported device/patient code(s) and provides general instructions for use, as well as warnings, precautions and potential complications associated with the device.Upon receipt of new or additional information, a follow-up report will be submitted as applicable.H11: section a through f ¿ the information provide by bd represents all the known information at this time.Despite good faith efforts to obtain additional information, the complainant/reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
 
Event Description
It was reported through the litigation process that sometime post a port placement, the patient was allegedly diagnosed with a stroke.The current status of the patient is unknown.
 
Event Description
It was reported through the litigation process that sometime post a port placement, the patient allegedly experienced bacterial infection as the tip of the port was cultured which showed positive for methicillin resistance staphylococcus aureus.It was further reported that the patient was allegedly diagnosed with bacteremia and experienced stroke.Reportedly, the infected port was removed and new port was implanted.The current status of the patient is unknown.
 
Manufacturer Narrative
H10: manufacturing review: a manufacturing review was not requested as the lot number reported is unknown.Investigation summary: the device was not returned for evaluation.Medical records were provided and reviewed.Post port placement, patient with a history of bacteremia and concern for port infection.Patient underwent removal of infected port under fluoroscopically guidance.The tip of the port was cut and sent to pathology for further evaluation.Around two days later, culture report showed positive for methicillin resistance staphylococcus aureus.Around eleven days post first port removal, patient underwent placement of port for recurrent urinary tract infection and venous access is required for long term antibiotics.After placement, under fluoroscopic guidance noted catheter tip in the right atrium.Around two years and nine months post second port placement, patient presented to the emergency department for concern for infection of port-a-cath.The port flushes well but will not draw.Chest x-ray showed left sided chest port is seen with its tip over the right atrium.Around one month and nineteen days later, patient presented for portogram procedure showed normal port-a-cath venogram, good aspiration and injection.Around four months and three days later, patient underwent port removal procedure for port site infection.The port and catheter were removed in entirety.Around two days later, central line tip catheter culture report showed positive for methicillin resistance staphylococcus aureus.Around twenty-one days later, patient underwent third port placement procedure for chronic infection.Fluoroscopy confirmed with tip at the junction of superior vena cava and right atrium.Around ten months and twenty-four days later, urine culture report showed positive for escherichia coli.Therefore, the investigation is inconclusive for the reported adverse event as no objective evidence was provided for review.Furthermore, the clinical conditions alleged in the complaint cannot be confirmed.Based upon the available information, the definitive root cause is unknown.Labeling review: as the reported event did not allege a labeling or use related issue, a labeling review is not required.H10: b5, g2, g3, h6 (patient, method).H11: b2, b3.H11: section a through f ¿ the information provide by bd represents all the known information at this time.Despite good faith efforts to obtain additional information, the complainant/reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.H3 other text : device not returned.
 
Manufacturer Narrative
H10: as the lot number for the device was provided, a review of the device history records is currently being performed.The device has not been returned to the manufacturer for evaluation.The investigation of the reported event is currently underway.H10: d4 (expiry date: 10/2017), g3.H11: b3, b5, d1, d4, h6 (result, conclusion).H11: section a through f ¿ the information provide by bd represents all the known information at this time.Despite good faith efforts to obtain additional information, the complainant/reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.H3 other text : device not returned.
 
Event Description
It was reported through the litigation process that two years, five months and fifteen days post port placement via the right internal jugular vein, the patient allegedly experienced bacterial infection as the tip of the port was cultured which showed positive for methicillin resistance staphylococcus aureus.It was further reported that the patient was allegedly diagnosed with bacteremia and experienced stroke.Reportedly, the infected port was removed and new port was implanted.The current status of the patient is unknown.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
UNKNOWN PORT
Type of Device
PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR
Manufacturer (Section D)
C.R. BARD, INC. (BASD) -3006260740
605 north 5600 west
salt lake city 84116
Manufacturer (Section G)
BARD REYNOSA S.A. DE C.V. -9617592
blvd. montebello #1
parque industrial colonial
reynosa, tamaulipas 88780
MX   88780
Manufacturer Contact
brett curtice
800 w. rio salado pkwy
tempe, AZ 85281
4803032689
MDR Report Key18694128
MDR Text Key335195303
Report Number3006260740-2024-00491
Device Sequence Number1
Product Code LJT
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K063377
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Consumer,Health Professional
Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup,Followup
Report Date 04/22/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberUNKNOWN PORT
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 01/18/2024
Initial Date FDA Received02/13/2024
Supplement Dates Manufacturer Received04/08/2024
04/16/2024
Supplement Dates FDA Received04/12/2024
05/12/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention; Life Threatening;
Patient Age53 YR
Patient SexMale
-
-